8-K enGene Therapeutics Inc. 2026-09-08: filing_filed_at
| Value | {"value": "2026-09-08T07:33:18", "timezone": "US/Eastern (EDGAR acceptance, as filed)"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K enGene Therapeutics Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1980845/000119312526384380/0001193125-26-384380-in
Retrieved: 2026-09-08T13:38:37.568506+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/85993df4-0f99-4dbb-beb3-14e6b4b995d4
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1980845/000119312526384380/0001193125-26-384380-in
Retrieved: 2026-09-08T13:38:37.568506+02:00
Raw response sha256:
709a05eac786883cb03a4142d75c8998…Cite as: FACTANKER, https://factanker.com/fact/85993df4-0f99-4dbb-beb3-14e6b4b995d4
History
- no predecessors — first report